Delivery Order SPE2DB22D2206-SPE2DB25FGF18
Award Date
3/21/25
Potential Completion Date
4/11/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of POMALYST 1 MG CAPSULE 21S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 14, 2024 with a ceiling value of $68,816.28 and a completion date of June 5, 2024. The award is a delivery order contract, with a firm fixed price pricing type. This contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of POMALYST 1 MG CAPSULE 21S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $37,029.15 and is a firm fixed-price delivery order with an ultimate completion date of October 19, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply POMALYST 2 MG CAPSULE 21S, a specialty pharmaceutical product, with a ceiling value of $36,863.70 and a performance period through April 9, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceuticals and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $23,971.00, is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide POMALYST 2 MG CAPSULE 21S, a pharmaceutical product. The delivery order has a ceiling value of $12,287.90 and a firm fixed price pricing type. It was awarded on March 26, 2024 with an ultimate completion date of April 16, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp, the prime contractor, is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of POMALYST 2 MG CAPSULE 21S medication. The award has a ceiling value of $12,287.90 and is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,287.90 firm-fixed-price delivery order is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a Delivery Order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Office of the Chief Operating Officer, a civilian federal agency. The $93,453.80 firm-fixed-price contract is for the supply of POMALYST 4MG CAP, which is a medical product used for the treatment of certain types of cancer. The contract has an ultimate completion date of September 30, 2015 and was not set aside for any specific business category. Additionally, AmerisourceBergen holds a...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $12,084.50, this order is for the supply of 4562914807 POMALYST 4 MG CAPSULE 21S to support DLA medical facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 18, 2023. No set-aside designation was applied to this award. As a...